CW April 2002
Volume 11Issue Number 4 April 2002 ISSN 10593802 Immunotherapy for Prostate CancerProstatic acid phosphatase (PAP), a protein expressed specifically on prostate tissue can be used to target prostate cancer cells for immunotherapy. Delivered as a vaccine this protein can induce tumor specific cytotoxic T lymphocytes, which are cytoxic to PAP-positive tumor cells.
Go to Previous Page Go to Next Page Source & Additional Reading E. J. Small et al., 93rd Annual Meeting of the American Association of Cancer Research, San Francisco, CA. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW April 2002Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
